A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Insulin detemir
Voglibose
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Voglibose.
Insulin detemir
Vildagliptin
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Vildagliptin.
Insulin detemir
AICA ribonucleotide
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with AICA ribonucleotide.
Insulin detemir
Glymidine
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Glymidine.
Insulin detemir
Chlorphenoxamine
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.
Insulin detemir
Revefenacin
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.
Insulin detemir
Umeclidinium
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Umeclidinium.
Insulin detemir
Propiverine
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Propiverine.
Insulin detemir
Imidafenacin
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Imidafenacin.
Insulin detemir
Trimebutine
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.
Insulin detemir
Aclidinium
Aclidinium may increase the central nervous system depressant (CNS depressant) activities of Levomilnacipran.
Insulin detemir
Timepidium
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Timepidium.
Insulin detemir
Pipenzolate
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.
Insulin detemir
Emetonium iodide
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Emetonium iodide.
Insulin detemir
Fenpiverinium
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Fenpiverinium.
Insulin detemir
Camylofin
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Camylofin.
Insulin detemir
Diphemanil
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.
Insulin detemir
Penthienate
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Penthienate.
Insulin detemir
Dihexyverine
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.
Insulin detemir
Tiemonium iodide
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Tiemonium iodide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3